PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Urogynecology0 citations

Cost-Effectiveness of Sacrohysteropexy Versus Hysterectomy With Sacrocolpopexy

View Full Paper
LGLauren GriswoldKDKatherine L. DenglerEWEva K. Welch

Key Points

  • The study aims to evaluate the cost-effectiveness of sacrocolpopexy with supracervical hysterectomy compared to sacrohysteropexy.
  • Developed a decision tree model using TreeAge® software.
  • Expressed effectiveness in quality-adjusted life years (QALYs).
  • Estimated incremental cost-effectiveness ratio (ICER) between treatments.
  • Conducted probabilistic sensitivity analysis (PSA) and created cost-effectiveness acceptability curves.
  • SCH-SCP had an ICER of $59,820 per QALY compared to MISH.
  • MISH was linked to 648 additional major surgical procedures and 5 endometrial cancer cases for a cohort of 10,000.
  • SCH-SCP had a 55.4% probability of being cost-effective at a WTP of $100,000.

Abstract

Importance Limited evidence is available comparing the cost-effectiveness of mesh augmented repairs with and without uterine preservation. Our model suggests that minimally invasive supracervical hysterectomy with sacrocolpopexy (SCH-SCP) is cost-effective compared with minimally invasive sacrohysteropexy (MISH) as it decreases the number of subsequent major surgical procedures, endometrial cancer diagnoses, and endometrial cancer deaths. This information is useful for decision making at the health system level and should be considered in the surgical counseling discussion. Objective The objective of this study was to compare the cost-effectiveness of SCH-SCP versus MISH. Study Design A decision tree model using TreeAge ® software was developed to evaluate the cost-effectiveness of SCH-SCP compared with uterine-sparing MISH. Effectiveness was expressed in quality-adjusted life years (QALYs), and the willingness-to-pay (WTP) threshold was set to 100, 000 per QALY. The literature review provided probabilities, utilities, and cost data. We estimated the incremental cost-effectiveness ratio (ICER) between the 2 strategies, completed a probabilistic sensitivity analysis (PSA), and created a cost-effectiveness acceptability curve for WTP thresholds from 0 to 200, 000. Results SCH-SCP was a cost-effective strategy, with an ICER of 59, 820/QALY compared with MISH. For a cohort of 10, 000, MISH is associated with an additional 648 major surgical procedures, 5 endometrial cancer cases, and 2 endometrial cancer deaths. PSA revealed the chance of SCH-SCP being cost-effective was 55. 4% at a WTP of 100, 000 and 57. 9% at a WTP of 200, 000. Conclusion Our model suggests that SCH-SCP may be cost-effective compared with MISH. SCH-SCP decreases the number of additional major surgical procedures, endometrial cancer diagnoses, and endometrial cancer deaths in our analysis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Griswold et al. (2026) studied this question.

synapsesocial.com/papers/69be35f96e48c4981c6747fbhttps://doi.org/10.1097/spv.0000000000001842
Ask AI
Helpful
Bookmark
Share
View Full Paper